AstraZeneca Starts Patent Squabble With IVAX
AstraZeneca’s infringement claims come in response to IVAX’s recent Abbreviated New Drug Application filed with the U.S. Food and Drug Administration.
IVAX is seeking to market esomeprazole magnesium, a generic version of Nexium, before five of AstraZeneca’s patents expire.
The Anglo-Swedish pharmaceutical maker lodged...
To view the full article, register now.